Evidence map›Paper›PMID 40450208›Full record

ArticleBMC neurology2025

Sleep disorders in patients with multiple sclerosis.

Ebrahim Kouchaki, Sahar Bayat, Fatemeh Sadat Asgarian

Abstract read
In one paragraph

Article in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Nabiximols improves sleep architecture in multiple sclerosis: A prospective polysomnographic study.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ebrahim KouchakiAutoimmune Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran.
Sahar BayatDepartment of Epidemiology, Faculty of Health, Arak University of Medical Sciences, Arak, Iran.
Fatemeh Sadat AsgarianSocial Determinants of Health (SDH) Research Center, Kashan University of Medical Sciences, Kashan, Iran. fatisadat@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMultiple sclerosis (MS), affected about 2.8 million people worldwide in 2020, is often associated with sleep disorders. These disturbances may arise from the disease itself-such as pain-or as side effects of symptomatic and immunological treatments.

methodsThe present study is cross-sectional- analytic study. The population studied consists of MS patients living in Kashan city. The sample size under investigation is comprised of 174 patients diagnosed with MS. The information was gathered through demographic information questionnaires, the hospital anxiety and depression scale(HADS), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), Insomnia Severity Index (ISI), and Multiple Sclerosis Impact Scale (MSIS). The data were analyzed through Chi-square tests and logistic regression using Stata version 14 software.

resultsOf 174 MS patients (81.76% female, mean age 34.16 ± 7.62), Mild insomnia affected 17.05%, and 68.18% experienced frequent night awakenings. Significant predictors of sleepiness included education level (OR: 18.20; p = 0.03), insomnia severity (OR: 5.24; p = 0.04), and morning dysfunction (OR: 6.49; p = 0.04), as well as MS medication. Most patients were not taking sleep medication (86.05%). Mild anxiety and baseline depressive symptoms were prevalent (69.32% and 80.68%, respectively), and 80.11% reported low quality of life.

conclusionsThe final model demonstrated an effective relationship between the Sleepiness and variables of education level, drugs used in MS, Insomnia Severity, and morning dysfunction in the presence of other variables.

Indexed as

Multiple SclerosisSleep Wake DisordersAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedSeverity of Illness IndexSurveys and QuestionnairesYoung AdultInsomniaMultiple sclerosisSleep disorders

Identifiers

PMID40450208
PMCPMC12125843

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.